| 1160 |
increased |
abnormal reproductive system development
(MP:0003936)
|
female reproductive organ
(UBERON:0003134)
|
2463: Early vaginal opening
|
| 1159 |
decreased |
reproductive process
(GO:0022414)
|
population of organisms
(PCO:0000001)
|
2462: Yield loss in rice
|
| 1158 |
decreased |
seed development
(GO:0048316)
|
|
2461: Reduced, grain filling
|
| 1157 |
decreased |
growth
(GO:0040007)
|
|
2460: Reduced, biomass accumulation
|
| 1156 |
decreased |
carbon fixation
(GO:0015977)
|
chloroplast
(GO:0009507)
|
2459: Reduced carbon fixation in Calvin cycle
|
| 1155 |
decreased |
ATP biosynthetic process
(GO:0006754)
|
chloroplast ATP synthase complex
(GO:0009544)
|
2458: Reduced, assimilatory power
|
| 1154 |
decreased |
photosynthetic electron transport chain
(GO:0009767)
|
photosystem II
(GO:0009523)
|
2457: Decreased, electron transport in photosystem II
|
| 1153 |
decreased |
photosynthesis, light reaction
(GO:0019684)
|
photosystem II
(GO:0009523)
|
2456: Photosystem II inhibition
|
| 1152 |
disrupted |
Abnormality of cellular immune system
(HP:0010987)
|
activated CD8-positive, alpha-beta T cell
(CL:0000906)
|
2326: CTL cytotoxic activity disruption
|
| 1151 |
abnormal |
Abnormality of cellular immune system
(HP:0010987)
|
alpha-beta T cell
(CL:0000789)
|
2324: Increased of Treg/Th17 cell ratio
|
| 1150 |
increased |
Abnormality of cellular immune system
(HP:0010987)
|
B7-related protein
(PR:000001290)
|
2323: Over-expression of PD-L1 in cancer cells
|
| 1149 |
increased |
androgen receptor signaling pathway
(GO:0030521)
|
Musculature of female perineum
(FMA:264623)
|
2365: Anogenital distance (AGD), increased
|
| 1148 |
occurrence |
Amyotrophic lateral sclerosis
(HP:0007354)
|
adult central nervous system
(UBERON:6003623)
|
2416: human amyotrophic lateral sclerosis (ALS)
|
| 1147 |
increased |
protein oxidation
(GO:0018158)
|
|
1767: Increase, Protein oxidation
|
| 1146 |
increased |
Hepatic bridging fibrosis
(HP:0012852)
|
|
2414: COL3A1 Signaling Pathway
|
| 1145 |
increased |
female gonad development
(GO:0008585)
|
immature gonad
(UBERON:2005272)
|
2417: Increased, differentiation to ovaries
|
| 1144 |
increased |
female sex determination
(GO:0030237)
|
population of organisms
(PCO:0000001)
|
2418: Increased, phenotypic female-biased sex ratio
|
| 1143 |
increased |
female gonad development
(GO:0008585)
|
|
None
|
| 1142 |
increased |
female gonad development
(GO:0008585)
|
female organism
(UBERON:0003100)
|
None
|
| 1141 |
increased |
abnormal reproductive system development
(MP:0003936)
|
reproductive organ
(UBERON:0003133)
|
2415: Precocious puberty
|
| 1140 |
increased |
increased uterus weight
(MP:0004904)
|
body of uterus
(UBERON:0009853)
|
2413: Increased, uterine weight
|
| 1139 |
increased |
increased circulating estradiol level
(MP:0005182)
|
17beta-estradiol
(CHEBI:16469)
|
2294: Plasma estradiol, increased
|
| 1138 |
increased |
neurotransmitter secretion
(GO:0007269)
|
Metastin
(CHEBI:80304)
|
1985: Increased Kisspeptin levels in anteroventral periventricular nucleus (AVPV)
|
| 1137 |
increased |
regulation of steroid hormone biosynthetic process
(GO:0090030)
|
17beta-estradiol
(CHEBI:16469)
|
2402: Increased, estradiol (E2) production in ovaries
|
| 1136 |
decreased |
neuropeptide signaling pathway
(GO:0007218)
|
Metastin
(CHEBI:80304)
|
None
|